8-K - Armata Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement Amendments to Existing Credit Agreements On January 23, 2026, Armata Pharmaceuticals, Inc. (the “Company”) entered in

Material Agreement

Source Document

9.01

Financial Statements and Exhibits. Exhibit No. Description 4.1 Warrant Amendment, dated January 23, 2026. 10.1 First Amendment to March 2025 Credit Agreement, d

Exhibits Only

Exhibits (7)

10.1

EXHIBIT 10.1

10.2

EXHIBIT 10.2

10.3

EXHIBIT 10.3

10.4

EXHIBIT 10.4

10.5

EXHIBIT 10.5

4.1

EXHIBIT 4.1

8-K

FORM 8-K